MaxLinear, Inc (MXL) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Bronstein, Gewirtz & Grossman, is investigating potential claims against MaxLinear, Inc (NYSE:MXL) on behalf of investors. The investigation follows MaxLinear's announcement of its Q2 2024 results, which revealed a 50% year-over-year decline in net revenue to $92 million. The company attributed this drop to prolonged customer inventory burn-off and weakened demand. Following this news, MaxLinear's stock price fell 37.1% to close at $14.02 on July 25, 2024.
Investors who purchased MaxLinear securities are encouraged to assist the investigation by visiting bgandg.com/MXL. The law firm is representing investors on a contingency fee basis, seeking reimbursement for expenses and attorneys' fees only if successful. Bronstein, Gewirtz & Grossman, has a track record of recovering millions for investors in securities fraud class actions.
Bronstein, Gewirtz & Grossman sta indagando su potenziali reclami contro MaxLinear, Inc (NYSE:MXL) per conto degli investitori. L'indagine è seguita all'annuncio da parte di MaxLinear dei risultati del secondo trimestre 2024, che hanno rivelato un calo del 50% su base annua nei ricavi netti a $92 milioni. L'azienda ha attribuito questa diminuzione a un prolungato esaurimento delle scorte dei clienti e a una domanda ridotta. Dopo queste notizie, il prezzo delle azioni di MaxLinear è sceso del 37,1%, chiudendo a $14,02 il 25 luglio 2024.
Si invita gli investitori che hanno acquistato titoli MaxLinear a sostenere l'indagine visitando bgandg.com/MXL. Lo studio legale rappresenta gli investitori su base di parcella solo in caso di successo, cercando il rimborso delle spese e delle spese legali. Bronstein, Gewirtz & Grossman ha una comprovata esperienza nel recupero di milioni per investitori in azioni collettive per frode di titoli.
Bronstein, Gewirtz & Grossman está investigando posibles reclamaciones contra MaxLinear, Inc (NYSE:MXL) en nombre de los inversores. La investigación sigue al anuncio de MaxLinear de sus resultados del segundo trimestre de 2024, que revelaron un declive del 50% interanual en los ingresos netos a $92 millones. La compañía atribuyó esta caída a un prolongado agotamiento del inventario de los clientes y a una demanda debilitada. Tras esta noticia, el precio de las acciones de MaxLinear cayó un 37.1% para cerrar en $14.02 el 25 de julio de 2024.
Se alienta a los inversores que compraron valores de MaxLinear a asistir en la investigación visitando bgandg.com/MXL. El bufete de abogados representa a los inversores en base a honorarios de contingencia, buscando el reembolso de gastos y honorarios legales solo si tiene éxito. Bronstein, Gewirtz & Grossman tiene un historial de recuperar millones para los inversores en acciones colectivas por fraude de valores.
브론스타인, 게위르츠 & 그로스만은 투자자를 대신하여 맥스리니어(MaxLinear, Inc) (NYSE:MXL)에 대한 잠재적인 청구를 조사하고 있습니다. 이 조사는 맥스리니어가 2024년 2분기 실적을 발표한 후 진행되었으며, 이 발표에서 순매출이 전년 대비 50% 감소하여 9,200만 달러에 이르렀다는 사실이 드러났습니다. 회사는 이러한 감소를 고객 재고 소진의 장기화와 수요 약화에 기인했다고 설명했습니다. 이 소식 이후, 맥스리니어의 주가는 37.1% 하락하여 2024년 7월 25일 $14.02로 마감했습니다.
맥스리니어 증권을 구매한 투자자들은 bgandg.com/MXL을 방문하여 조사에 협조할 것을 권장합니다. 이 법률 사무소는 성공할 경우에만 비용 및 변호사 수임료에 대한 환급을 요구하며, 수익 분배를 기반으로 투자자를 대리하고 있습니다. 브론스타인, 게위르츠 & 그로스만은 증권 사기 집단 소송에서 투자자들을 위해 수백만 달러를 회수한 경력이 있습니다.
Bronstein, Gewirtz & Grossman enquête sur d'éventuelles réclamations contre MaxLinear, Inc (NYSE:MXL) au nom des investisseurs. L'enquête fait suite à l'annonce par MaxLinear de ses résultats du deuxième trimestre 2024, qui ont révélé un baisse de 50 % des revenus nets d'une année sur l'autre à 92 millions de dollars. La société a attribué cette chute à une érosion prolongée des stocks chez ses clients et à une demande affaiblie. À la suite de cette nouvelle, le prix des actions de MaxLinear a chuté de 37,1 % pour clôturer à 14,02 $ le 25 juillet 2024.
Les investisseurs ayant acheté des titres MaxLinear sont encouragés à participer à l'enquête en visitant bgandg.com/MXL. Le cabinet d'avocats représente les investisseurs sur une base de frais de succès, cherchant à récupérer les dépenses et les honoraires d'avocat uniquement en cas de réussite. Bronstein, Gewirtz & Grossman a un bilan de récupération de millions pour les investisseurs dans des actions collectives pour fraude aux valeurs mobilières.
Bronstein, Gewirtz & Grossman untersucht mögliche Ansprüche gegen MaxLinear, Inc (NYSE:MXL) im Namen von Investoren. Die Untersuchung folgt auf die Bekanntgabe der Ergebnisse von MaxLinear für das 2. Quartal 2024, die einen Rückgang der Nettoumsätze um 50% im Jahresvergleich auf 92 Millionen US-Dollar zeigten. Das Unternehmen führte diesen Rückgang auf eine anhaltende Ausmusterung von Kundenbeständen und eine schwache Nachfrage zurück. Nach dieser Nachricht
Investoren, die MaxLinear-Werte gekauft haben, werden ermutigt, die Untersuchung zu unterstützen, indem sie bgandg.com/MXL besuchen. Die Kanzlei vertritt Investoren auf einer Erfolgsbasis und sucht eine Erstattung für Ausgaben und Anwaltsgebühren nur im Erfolgsfall. Bronstein, Gewirtz & Grossman hat eine Erfolgsbilanz bei der Rückführung von Millionen für Investoren in Wertpapierbetrugs-Klageverfahren.
- None.
- 50% year-over-year decline in Q2 2024 net revenue to $92 million
- Stock price fell 37.1% following Q2 2024 results announcement
- Prolonged customer inventory burn-off leading to weakened demand
- Potential legal claims against the company being investigated
This investigation into MaxLinear (MXL) is a significant development for investors. The
Investors should be aware that such investigations often lead to class-action lawsuits. If wrongdoing is found, it could result in financial settlements and potential leadership changes. However, it's important to note that at this stage, these are allegations and no wrongdoing has been proven. Shareholders should monitor the situation closely and consider seeking legal advice to understand their rights and potential for compensation.
The
Investors should scrutinize upcoming quarters for signs of recovery or further deterioration. Key metrics to watch include inventory levels, cash flow and guidance. If inventory burn-off is indeed the primary issue, we should see improvements in the coming quarters. However, if problems persist, it could signal more systemic challenges in MaxLinear's business model or market position.
NEW YORK CITY, NY / ACCESSWIRE / August 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MaxLinear, Inc ("MaxLinear" or "the Company") (NYSE:MXL). Investors who purchased MaxLinear securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MXL.
Investigation Details
On July 24, 2024, MaxLinear issued a press release announcing its second quarter 2024 results, including net revenue for the quarter amounting to just
What's Next?
If you are aware of any facts relating to this investigation or purchased MaxLinear securities, you can assist this investigation by visiting the firm's site: bgandg.com/MXL. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on accesswire.com
FAQ
What caused MaxLinear's (MXL) stock price to drop in July 2024?
Why is MaxLinear (MXL) under investigation by Bronstein, Gewirtz & Grossman?
What were MaxLinear's (MXL) Q2 2024 financial results?
How can investors participate in the MaxLinear (MXL) investigation?
